How do I set a price alert for BAX?

To set a BAX price alert on Stock Alarm Pro, navigate to the BAX quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for BAX?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for BAX. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for Baxter International?

Stock Alarm Pro supports over 125 trigger types for BAX: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about BAX price changes?

BAX alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for BAX alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for BAX and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

Baxter International (BAX) Price Alerts

Demo Sign up Log In

Baxter International Inc.(BAX)

NYSEUpdated 1:06 PM ESTAbout this dataData status

$26.14▼-0.20 (-0.74%)

WatchlistChart Studio

BAX(BAX)

BAX

S&P 500, Nasdaq, Russell 2000 below the 50-day average

Market overview →Overview →

Explore More

BAX Financial Metrics

Explore 130+ historical metrics & ratios

Healthcare Stocks

More Healthcare stocks

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

BAX Fundamentals

Annual and trailing 12-month values

All metrics →All fundamentals →

BAX News

All news →

About

baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Sector

Manufacturing

Industry

Surgical and Medical Instrument Manufacturing

CEO

Jose Almeida

Website

baxter.com ↗

Leadership (14)

Andrew HiderChief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director

Bernie HeineInterim Chief Accounting Officer & Controller

Charles PatelSenior Vice President & Chief Information Officer

David S. RosenbloomExecutive Vice President & General Counsel

James W. BorziExecutive Vice President & Chief Supply Chain Officer

John Terence RogersExecutive Vice President & Chief Financial Officer

Piero NovelloSenior Vice President and President of International

Scott KaplanSenior Vice President of Quality, Regulatory & Patient Safety

Steven WallacePresident of Advanced Surgery & Commercial Excellence

Anita A. ZielinskiInterim CFO, Senior VP, Chief Accounting Officer & Controller

Cynthia CarlisleExecutive Vice President & Chief Human Resources Officer

Maria SorianoGroup President of Infusion Therapies & Platforms

Stacey EisenSVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation

Kevin MoranVice President & Head of Investor Relations

About

Outlook

10 analystsHold$22.50-13.9%

TrendUptrend6.5% above 50-day

Key Metrics

TTMAll charts →

Select a linked metric to explore its chart.

Market Cap$13.53B Revenue TTM$11.61B

Rev Growth FY26E+4.3%

Rev Growth YoY+5.3%Price / Sales1.2x P/E (TTM)12.6x

Fwd P/E FY26E12.4x

Net Income TTM-$723.00M Free Cash Flow$1.00B Gross Margin30.1%Operating Margin-1.9%Net Margin-6.2%Return on Equity-11.6%

Return on Assets-3.7%

Debt / Equity (MRQ)1.35 Current Ratio (MRQ)1.79 EPS TTM$-1.40

All BAX metrics →Financial statements →

Trading snapshot

Price & range

Prev Close

26.34

Open

26.60

Day Range25.87 – 26.66

25.87

26.66

52W Range15.73 – 30.00

15.73

30.00

73% of range

50-Day MA

24.55(+6.5%)

200-Day MA

21.57(+21.2%)

Volume & size

Avg Volume

7.1M

Valuation & risk

P/E (TTM)

12.6x

Value territory

EPS (TTM)

—

Div Yield (TTM)

2.19%

Beta

0.55

Low vol

Momentum

RSI (14)

57

Bullish momentum

Upcoming Events

DEx-Dividend

In 15 days

Nov 27

PDividend Pay

In 53 days

Jan 4

EEarnings Report

In 91 days

Feb 11

Explore More

S&P 500 Sector Leaderboards

Fundamental Metric Rankings

BAX Fundamentals

BAX News

About

Leadership (14)

About

About

Leadership (14)

Upcoming Events

Outlook

Key Metrics

BAX Fundamentals